The leading source for credible citizen reporting

Report Your News
Take the tour...

This event is older than two months and is no longer active. Some links older than two months could be broken.

Report Your News

Click here to post a new related report

WebMD: Marijuana Chemical May Fight Brain Cancer

Madrid : Spain | 8 months ago  
Views: 0
Guillermo Velasco and colleagues at Complutense University in Spain have found that the active ingredient in marijuana, THC, causes brain cancer cells to undergo a process called autophagy. Autophagy is the breakdown of a cell that occurs when the cell essentially self-digests.
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon

Related Allvoices Contributions

News Stories
 
  • News Source: Fox News | 8 months ago
    The active ingredient in marijuana appears to reduce tumor growth, according to a Spanish study published on Wednesday. The researchers showed giving THC to mice with cancer decreased tumor growth and killed cells off in a process called autophagy. "...
  • News Source: Daily News & Analysis | 8 months ago
    Two patients with recurrent glioblastoma multiforme (a highly aggressive brain tumor) received THC treatment on the skull and showed signs of autophagy, prompting them to zero upon the curative values of marijuana. "The potential use of cannabinoid (...
  • News Source: Uinta County News | 8 months ago
    New research out of Spain suggests that THC -- the active ingredient in marijuana -- appears to prompt the death of brain cancer cells. The finding is based on work with mice designed to carry human cancer tumors, as well as from an analysis of THC's...
  • News Source: Uinta County News | 8 months ago
    Guillermo Velasco and colleagues at Complutense University in Spain have found that the active ingredient in marijuana, THC, causes brain cancer cells to undergo a process called autophagy. Autophagy is the breakdown of a cell that occurs when the...
  • News Source: Androscoggin News | 8 months ago
    Their report, to be published in the Journal of Clinical Oncology and receiving early online release, describes how treatment with the experimental drug cediranib reduced edema and improved survival in three mouse models of glioblastoma. "Our...
Most Popular Reports

Contributions

Help and Accounts


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.